Methotrexate sodium and Enterobacter sepsis - a phase IV clinical study of FDA data

Summary:

Enterobacter sepsis is reported as a side effect among people who take Methotrexate sodium (methotrexate sodium), especially for people who are male, 60+ old, also take Enoxaparin Sodium, and have High blood pressure.

The phase IV clinical study analyzes which people have Enterobacter sepsis when taking Methotrexate sodium. It is created by eHealthMe based on reports of 96,366 people who have side effects when taking Methotrexate sodium from the FDA, and is updated regularly.

What is Methotrexate sodium?

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 97,680 Methotrexate sodium users. Check the latest studies of Methotrexate sodium.

What is Enterobacter sepsis?

Enterobacter sepsis (sepsis due to bacteria of the family enterobacteriaceae) is found to be associated with 73 drugs and 217 conditions by eHealthMe. Check the latest studies of Enterobacter sepsis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

96,366 people reported to have side effects when taking Methotrexate sodium.
Among them, 16 people (0.02%) have Enterobacter sepsis.

Could Methotrexate sodium cause Enterobacter sepsis?

Among these 16 people:

What is the gender of people who have Enterobacter sepsis when taking Methotrexate sodium? *

  • female: 18.75 %
  • male: 81.25 %

What is the age of people who have Enterobacter sepsis when taking Methotrexate sodium? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 13.33 %
  • 40-49: 0.0 %
  • 50-59: 20.0 %
  • 60+: 66.67 %

What are other drugs people take besides Methotrexate sodium? *

  1. Prednisolone: 10 people, 62.50%
  2. Folic Acid: 10 people, 62.50%
  3. Enoxaparin Sodium: 10 people, 62.50%
  4. Cotrim: 9 people, 56.25%
  5. Methotrexate: 6 people, 37.50%
  6. Ciprofloxacin: 5 people, 31.25%
  7. Ciprofloxacin Hydrochloride: 4 people, 25.00%
  8. Cytarabine: 3 people, 18.75%
  9. Bisoprolol Fumarate And Hydrochlorothiazide: 3 people, 18.75%
  10. Rydapt: 3 people, 18.75%

What are other side effects people have besides Enterobacter sepsis? *

  1. Urinary Tract Infection: 10 people, 62.50%
  2. Urinary Retention (the inability to completely or partially empty the bladder): 10 people, 62.50%
  3. Urinary Hesitation (difficulty in beginning the flow of urine): 10 people, 62.50%
  4. Gastroenteritis (inflammation of stomach and intestine): 10 people, 62.50%
  5. High Blood Pressure: 10 people, 62.50%
  6. Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 10 people, 62.50%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 62.50%
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 10 people, 62.50%
  9. Post Procedural Haematuria (post procedural blood in urine): 10 people, 62.50%
  10. Femoral Neck Fracture (neck of femur bone fracture): 7 people, 43.75%

What are the existing conditions these people have? *

  1. Urinary Tract Infection: 9 people, 56.25%
  2. Urinary Retention (the inability to completely or partially empty the bladder): 9 people, 56.25%
  3. High Blood Pressure: 9 people, 56.25%
  4. Sepsis (a severe blood infection that can lead to organ failure and death): 8 people, 50.00%
  5. Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 2 people, 12.50%
  6. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate sodium and have Enterobacter sepsis?

- Check whether Enterobacter sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methotrexate sodium:

Enterobacter sepsis treatments and more:

How severe was Enterobacter sepsis and when was it recovered:

Expand to all the drugs that have ingredients of methotrexate sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterobacter sepsis:

Browse all the conditions that are associated with Enterobacter sepsis:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate sodium) and Methotrexate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: